Tran, S., Sipila, P., Frigault, M. M., Stelte-Ludwig, B., Johnson, A. J., Birkett, J., . . . Narendran, A. Enitociclib, a selective CDK9 inhibitor: In vitro and in vivo preclinical studies in multiple myeloma. Elsevier.
Chicago Style (17th ed.) CitationTran, Son, et al. Enitociclib, a Selective CDK9 Inhibitor: In vitro and In vivo Preclinical Studies in Multiple Myeloma. Elsevier.
MLA (9th ed.) CitationTran, Son, et al. Enitociclib, a Selective CDK9 Inhibitor: In vitro and In vivo Preclinical Studies in Multiple Myeloma. Elsevier.
Warning: These citations may not always be 100% accurate.